Home › Funds › ADAR1 Capital Management, LLC › ZLAB
ADAR1 Capital Management, LLC position in ZLAB
Zai Lab Ltd · Health Care
ADAR1 Capital Management, LLC reported holding 3,369,034 shares of ZLAB (Zai Lab Ltd) in its Q2 2026 13F filing — a position valued at US$64.0M, representing 3.55% of its reported portfolio and ranking #4 among its reported holdings. ADAR1 Capital Management, LLC has disclosed ZLAB holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ADAR1 Capital Management, LLC's ZLAB position evolved
ADAR1 Capital Management, LLC first disclosed a stake in ZLAB in Q4 2023 at 20,000 shares (US$547K). The position peaked in Q2 2026 at 3,369,034 shares, worth US$64.0M. Across 11 filings, ADAR1 Capital Management, LLC increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 3,369,034 shares valued at US$64.0M — an increase of 1,943,667 shares quarter over quarter.. Notable position changes include a 2320% increase in Q3 2024 (shares rose 8% over the following quarter), a 96% increase in Q4 2024 (shares rose 38% over the following quarter), a 136% increase in Q2 2026 (shares rose 39% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 20.00K | $546.60K | New |
| Q1 2024 | 22.00K | $352.44K | Add |
| Q2 2024 | 22.00K | $381.26K | Hold |
| Q3 2024 | 532.45K | $12.85M | Add |
| Q4 2024 | 1.05M | $27.39M | Add |
| Q1 2025 | 940.86K | $34.00M | Reduce |
| Q2 2025 | 850.44K | $29.74M | Reduce |
| Q3 2025 | 868.78K | $29.44M | Add |
| Q4 2025 | 1.25M | $21.99M | Add |
| Q1 2026 | 1.43M | $26.81M | Add |
| Q2 2026 | 3.37M | $64.01M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZLAB and 13F data
ZLAB (Zai Lab Ltd) is a Health Care company. 14 other funds we track also report a position in ZLAB — the largest reported positions include RTW INVESTMENTS, LP (US$124.9M), TCG Crossover Management, LLC (US$116.6M), RA CAPITAL MANAGEMENT, L.P. (US$109.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZLAB
- RTW INVESTMENTS, LP 6.57M sh · $124.91M · Q2 2026
- TCG Crossover Management, LLC 6.14M sh · $116.61M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 5.74M sh · $109.13M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.90M sh · $36.14M · Q2 2026
- Rock Springs Capital Management LP 814.71K sh · $15.48M · Q2 2026
- B Group, Inc. 450.65K sh · $8.56M · Q2 2026
More on ADAR1 Capital Management, LLC
FAQ
How long has ADAR1 Capital Management, LLC held ZLAB?
ADAR1 Capital Management, LLC has disclosed ZLAB holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is ADAR1 Capital Management, LLC's current position in ZLAB?
As of Q2 2026, ADAR1 Capital Management, LLC holds 3.37M shares of ZLAB (Zai Lab Ltd), valued at $64.01M, representing 3.55% of its reported portfolio and ranking #4.
Has ADAR1 Capital Management, LLC been buying or selling ZLAB?
In the latest 13F filing (Q2 2026), ADAR1 Capital Management, LLC increased its position in ZLAB. The position peaked in Q2 2026 at 3.37M shares.
Which other funds hold ZLAB?
Other major institutional holders of ZLAB include RTW INVESTMENTS, LP, TCG Crossover Management, LLC, RA CAPITAL MANAGEMENT, L.P., among 14 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.